Bruker Corporation

NasdaqGS:BRKR Stock Report

Market Cap: US$8.4b

Bruker Management

Management criteria checks 4/4

Bruker's CEO is Frank Laukien, appointed in Feb 1991, has a tenure of 33.83 years. total yearly compensation is $5.86M, comprised of 15.8% salary and 84.2% bonuses, including company stock and options. directly owns 26.62% of the company’s shares, worth $2.23B. The average tenure of the management team and the board of directors is 10.7 years and 9.3 years respectively.

Key information

Frank Laukien

Chief executive officer

US$5.9m

Total compensation

CEO salary percentage15.8%
CEO tenure33.8yrs
CEO ownership26.6%
Management average tenure10.7yrs
Board average tenure9.3yrs

Recent management updates

Recent updates

Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Nov 14
Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Bruker: Still Challenged, Certainly Margins

Nov 02

Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

Oct 25
Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt

Sep 10
We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt

Bruker: Multiple Risks And Declining Returns On Capital Aren't Priced In

Aug 22

Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Jul 22
Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Jun 09
Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Bruker: A Confusing Acquisition Spree

May 31

Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

May 09
Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

Bruker Corporation: An Aggressive Acquisition Strategy

Apr 24

Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research

Apr 11

Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

Jan 22
Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Jan 08
There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

Dec 26
Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

CEO Compensation Analysis

How has Frank Laukien's remuneration changed compared to Bruker's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$305m

Jun 30 2024n/an/a

US$352m

Mar 31 2024n/an/a

US$402m

Dec 31 2023US$6mUS$926k

US$427m

Sep 30 2023n/an/a

US$319m

Jun 30 2023n/an/a

US$319m

Mar 31 2023n/an/a

US$312m

Dec 31 2022US$5mUS$873k

US$297m

Sep 30 2022n/an/a

US$275m

Jun 30 2022n/an/a

US$274m

Mar 31 2022n/an/a

US$282m

Dec 31 2021US$6mUS$812k

US$277m

Sep 30 2021n/an/a

US$270m

Jun 30 2021n/an/a

US$238m

Mar 31 2021n/an/a

US$204m

Dec 31 2020US$4mUS$689k

US$158m

Sep 30 2020n/an/a

US$158m

Jun 30 2020n/an/a

US$165m

Mar 31 2020n/an/a

US$177m

Dec 31 2019US$5mUS$753k

US$197m

Sep 30 2019n/an/a

US$207m

Jun 30 2019n/an/a

US$189m

Mar 31 2019n/an/a

US$184m

Dec 31 2018US$4mUS$731k

US$180m

Sep 30 2018n/an/a

US$98m

Jun 30 2018n/an/a

US$92m

Mar 31 2018n/an/a

US$84m

Dec 31 2017US$5mUS$704k

US$79m

Compensation vs Market: Frank's total compensation ($USD5.86M) is about average for companies of similar size in the US market ($USD7.88M).

Compensation vs Earnings: Frank's compensation has been consistent with company performance over the past year.

CEO

Frank Laukien (64 yo)

33.8yrs

Tenure

US$5,858,761

Compensation

Dr. Frank H. Laukien, Ph D., serves as the Chairman, Chief Executive Officer and President of Bruker Corporation at Bruker BioSpin GmbH since February 1991. Dr. Laukien serves as the Chairman, Chief Execut...

Leadership Team

NamePositionTenureCompensationOwnership
Frank Laukien
Chairman33.8yrsUS$5.86m26.62%
$ 2.2b
Gerald Herman
Executive VP & CFO6.8yrsUS$2.20m0.033%
$ 2.7m
Mark Munch
Corporate Executive VP and President of Bruker Nano Group & Corporate9.4yrsUS$2.73m0.050%
$ 4.2m
Juergen Srega
President of Bruker CALID Group & Bruker Daltonics Division11.9yrsUS$1.47m0.081%
$ 6.8m
Falko Busse
President of Bruker BioSpin Group6.6yrsUS$1.35m0.016%
$ 1.3m
Justin Ward
Senior Director of Investor Relations & Corporate Developmentno datano datano data
J. Alldredge
General Counsel & Secretaryno datano datano data
Burkhard Prause
President and CEO of Bruker Energy & Supercon Technologies16.7yrsUS$967.91k0.0090%
$ 753.9k

10.7yrs

Average Tenure

62yo

Average Age

Experienced Management: BRKR's management team is seasoned and experienced (10.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Frank Laukien
Chairman33.8yrsUS$5.86m26.62%
$ 2.2b
John Ornell
Independent Director9.3yrsUS$241.01k0.014%
$ 1.2m
Robert Rosenthal
Independent Director9.1yrsUS$224.01k0.019%
$ 1.6m
Richard Packer
Independent Director17.6yrsUS$227.32k0.052%
$ 4.3m
William Linton
Independent Lead Director24.8yrsUS$231.01k0.028%
$ 2.4m
Adelene Perkins
Independent Director7.6yrsUS$224.01k0.013%
$ 1.0m
Hermann Requardt
Independent Director9.3yrsUS$219.01k0.014%
$ 1.2m
Bonnie Anderson
Independent Director4.3yrsUS$219.65k0.0050%
$ 424.0k
Cynthia Friend
Independent Director8.6yrsUS$216.83k0.0076%
$ 641.4k

9.3yrs

Average Tenure

66yo

Average Age

Experienced Board: BRKR's board of directors are considered experienced (9.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 22:39
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bruker Corporation is covered by 34 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Luke SergottBarclays
Michael RyskinBofA Global Research
Derik de BruinBofA Global Research